VAERS Explorer
Back to explore

Report #2890285

Received Mar 23, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
Recovered
Unknown
Vaccinated
Onset
Days to onset
Hospital days

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TYPTYPHOID LIVE ORAL TY21A (VIVOTIF)BERNA BIOTECH, LTD.13004045PO / MO

Symptoms (1)

Product storage error

Symptom narrative

One box of Vivotif was at 76 degrees Fahrenheit for eight hours; patient took one pill; One box of Vivotif was at 76 degrees Fahrenheit for eight hours; patient took one pill; Case reference number US-BN-2024-002111 is a spontaneous case initially received from a consumer via agency (reference number: USBAV24-1511) on 27-Jun-2024 and concerns a patient of unknown demographics. The patient's medical history and concomitant medication details were not provided. On an unspecified date, reported as yesterday, the patient picked up Vivotif., but the pharmacist did not tell the patient that Vivotif needed to be refrigerated. One box of Vivotif was at 76 degrees Fahrenheit for eight hours (explicitly coded as 'Product storage error'). On 27-Jun-2024, the patient took the first dose of Vivotif (batch number: 3004045), at an unknown dose, orally, for an unknown indication (explicitly coded as 'Product administration error'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to the Vivotif vaccine. Non-significant follow up was downloaded from VAERS on 09-May-2025 included new reference number Administrative update performed within the case: Worldwide Unique Case Identification Number (WWID) updated from US-20240627-a38641 to US-BAVARIAN NORDIC A/S-US-BN-2024-002111, in accordance with ICH guidance on WWID formatting.; Reporter's Comments: A patient of unknown demographics picked up Vivotif, but the pharmacist did not tell the patient that Vivotif needed to be refrigerated. One box of Vivotif was at 76 degrees Fahrenheit for eight hours, which is considered as product storage error. Reportedly, the patient took the first dose of Vivotif for an unknown indication, which is considered as product administration error. It was unknown if the patient experienced any adverse event due to the Vivotif vaccine. Product storage error and product administration error are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product storage error and product administration error have been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A patient of unknown demographics picked up Vivotif, but the pharmacist did not tell the patient that Vivotif needed to be refrigerated. One box of Vivotif was at 76 degrees Fahrenheit for eight hours, which is considered as product storage error. Reportedly, the patient took the first dose of Vivotif for an unknown indication, which is considered as product administration error. It was unknown if the patient experienced any adverse event due to the Vivotif vaccine. Product storage error and product administration error are considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product storage error and product administration error have been considered as not related to the suspect vaccine, but to a human factor. This case is considered as non-serious. USBAV24-1511: